Diligence the private market with public-market discipline.
What's broken today, and how Enquire solves it.
The private market runs dark.
The companies you diligence have no analyst coverage, no consensus view, and are often absent from vendor lists entirely. Speed, depth, or expertise, public investors get to pick two. On a private name, you rarely get even one.
Institutional-grade coverage on any private name.
Enquire's Research Center stands up an analyst-grade knowledge base on the companies, themes, and markets the rest of the world doesn't cover, pairing proprietary analytical frameworks with an Expert Network of AI-moderated interviews. Speed, depth, and expertise, on a name no one else can see.
The founder's narrative is the only narrative.
Every deck tells a clean story. Separating durable insight from the pitch, the real moat, the real competitive set, the real risk, means weeks of expert calls you don't have in a hot round, so conviction leans on the story you were told.
Pressure-test the pitch against reality.
Enquire maps the real competitive set, scores the moat, and surfaces the underappreciated surprises the founder's deck leaves out, grounded in evidence and sources, not narrative. It tells you where a crowded space still has room for a winner and where the profit pool gets competed away.
Diligence starts from a blank page, every time.
New sector, new geography, new company. You reconstruct the landscape from scratch under deal-clock pressure, then do it all over again on the next opportunity, with nothing carrying forward.
Your first stop on any deal, in under an hour.
An Executive Investment Brief plus the central debates orients you fast: what the company is, what's actually contested, and what has to be true for the thesis to work. Blank page to a working view before the next partner meeting.
Conviction forms in a competitive sprint.
Rounds move fast and FOMO is real. It's easy to get missile-locked on the thesis you want to be true, or blindsided by the risk no one on the deal team pressure-tested before the wire went out.
Build conviction with discipline, not FOMO.
Thesis Stress Test, Devil's Advocate, Pre-Mortem, Gray Swan, and Red Team put more scrutiny on what can go wrong than what can go right, probability-weighted, with the signposts that would change your mind mapped before you commit.
The work doesn't compound, and the portfolio doesn't scale.
Diligence memos die in a folder. Your team is small, coverage keeps widening across sectors and stages, and the operating help portfolio companies need outruns the hours you have. Human attention doesn't scale to the surface area you're now asked to cover.
Coverage and portfolio support that compound.
Enquire is an independent research team you can assign coverage to, across every sector and stage, that preserves debates, assumptions, and evidence over time and gets smarter each cycle. Analytical and operating capacity for the whole portfolio, without adding headcount.
"A venture investor tried to break the platform with an obscure private software company, repo-collateral software, roughly 30 competitors, zero analyst coverage. Enquire surfaced a real, underappreciated surprise the consensus had missed entirely: a Euroclear embedding and Tier-1 bank wins with Citi and Nomura, signals invisible everywhere else because the company was simply absent from vendor lists. The investor was shocked it worked."
Capability demonstrated in a recorded product demo
Request a Demo
Start free, or book a guided demo on a name you cover.